|
US4916135A
(en)
|
1989-05-08 |
1990-04-10 |
Hoechst Roussel Pharmaceuticals Inc. |
N-heteroaryl-4-quinolinamines
|
|
US5710158A
(en)
|
1991-05-10 |
1998-01-20 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
PT100905A
(pt)
|
1991-09-30 |
1994-02-28 |
Eisai Co Ltd |
Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
|
|
AU661533B2
(en)
|
1992-01-20 |
1995-07-27 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
JP2994165B2
(ja)
*
|
1992-06-26 |
1999-12-27 |
ゼネカ・リミテッド |
キナゾリン誘導体、その製造法および該キナゾリン誘導体を含有する抗癌作用を得るための医薬調剤
|
|
GB9510757D0
(en)
*
|
1994-09-19 |
1995-07-19 |
Wellcome Found |
Therapeuticaly active compounds
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
US6046206A
(en)
|
1995-06-07 |
2000-04-04 |
Cell Pathways, Inc. |
Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
|
|
PT912559E
(pt)
|
1996-07-13 |
2003-03-31 |
Glaxo Group Ltd |
Compostos heterociclicos fundidos como inibidores de proteina tirosina quinase
|
|
WO1998005647A1
(en)
|
1996-08-01 |
1998-02-12 |
Dow Agrosciences Llc |
Quinolinium derivatives having fungicidal activity
|
|
WO1998013350A1
(en)
|
1996-09-25 |
1998-04-02 |
Zeneca Limited |
Qinoline derivatives inhibiting the effect of growth factors such as vegf
|
|
UA73073C2
(uk)
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
GB9800569D0
(en)
*
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
|
NZ510210A
(en)
|
1998-10-01 |
2003-06-30 |
Astrazeneca Ab |
4-phenylamino substituted quinazoline or quinoline derivatives useful for treating cytokine mediated diseases or conditions
|
|
GB2345486A
(en)
|
1999-01-11 |
2000-07-12 |
Glaxo Group Ltd |
Heteroaromatic protein tyrosine kinase inhibitors
|
|
CN1391562A
(zh)
|
1999-09-21 |
2003-01-15 |
阿斯特拉曾尼卡有限公司 |
用作药物的喹唑啉衍生物
|
|
EP1294709A2
(en)
|
2000-01-28 |
2003-03-26 |
AstraZeneca AB |
Quinoline derivatives and their use as aurora 2 kinase inhibitors
|
|
MXPA02007957A
(es)
|
2000-02-17 |
2002-11-29 |
Amgen Inc |
Inhibidores de cinasas.
|
|
US6521618B2
(en)
|
2000-03-28 |
2003-02-18 |
Wyeth |
3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
|
|
US6589758B1
(en)
|
2000-05-19 |
2003-07-08 |
Amgen Inc. |
Crystal of a kinase-ligand complex and methods of use
|
|
CA2415469A1
(en)
|
2000-08-09 |
2002-02-14 |
Astrazeneca Ab |
Quinoline derivatives having vegf inhibiting activity
|
|
US6548508B2
(en)
|
2000-10-20 |
2003-04-15 |
Pfizer, Inc. |
Use of PDE V inhibitors for improved fecundity in mammals
|
|
GB0025782D0
(en)
|
2000-10-20 |
2000-12-06 |
Pfizer Ltd |
Use of inhibitors
|
|
GB0104422D0
(en)
|
2001-02-22 |
2001-04-11 |
Glaxo Group Ltd |
Quinoline derivative
|
|
ATE353889T1
(de)
|
2001-03-23 |
2007-03-15 |
Bayer Pharmaceuticals Corp |
Rho-kinase inhibitoren
|
|
WO2002076976A2
(en)
|
2001-03-23 |
2002-10-03 |
Bayer Corporation |
Rho-kinase inhibitors
|
|
SE0101675D0
(sv)
|
2001-05-11 |
2001-05-11 |
Astrazeneca Ab |
Novel composition
|
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
|
WO2003026665A1
(en)
|
2001-09-26 |
2003-04-03 |
Bayer Pharmaceuticals Corporation |
2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors
|
|
MXPA04006260A
(es)
|
2001-12-24 |
2005-03-31 |
Astrazeneca Ab |
Derivados de quinazolina sustituidos como inhibidores de cinasas aurora.
|
|
US7645878B2
(en)
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
|
TWI275390B
(en)
|
2002-04-30 |
2007-03-11 |
Wyeth Corp |
Process for the preparation of 7-substituted-3- quinolinecarbonitriles
|
|
AU2003255482A1
(en)
*
|
2002-10-02 |
2004-04-23 |
Merck Patent Gmbh |
Use of 4 amino-quinazolines as anti cancer agents
|
|
WO2004037814A1
(en)
|
2002-10-25 |
2004-05-06 |
Vertex Pharmaceuticals Incorporated |
Indazolinone compositions useful as kinase inhibitors
|
|
US20040122161A1
(en)
|
2002-12-21 |
2004-06-24 |
Paul Charles W. |
Hot melt adhesive based on acrylic block copolymers
|
|
AU2003290313B2
(en)
|
2002-12-24 |
2007-05-10 |
Astrazeneca Ab |
Phosphonooxy quinazoline derivatives and their pharmaceutical use
|
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
|
JP2007501854A
(ja)
|
2003-05-27 |
2007-02-01 |
ファイザー・プロダクツ・インク |
受容体型チロシンキナーゼ阻害薬としてのキナゾリン類およびピリド［３，４−ｄ］ピリミジン類
|
|
JP5129957B2
(ja)
|
2003-07-03 |
2013-01-30 |
ミリアド ジェネティクス， インコーポレイテッド |
カスパーゼの活性化因子およびアポトーシスの誘発因子としての４−アリールアミノ−キナゾリン
|
|
BRPI0414489A8
(pt)
|
2003-09-16 |
2019-01-15 |
Astrazeneca Ab |
derivado de quinazolina, composição farmacêutica, uso de um derivado de quinazolina, e, processo para a preparação de um derivado de quinazolina
|
|
EP2392565B1
(en)
|
2003-09-26 |
2014-03-19 |
Exelixis, Inc. |
c-Met modulators and methods of use
|
|
AU2005249503B2
(en)
|
2003-11-10 |
2011-08-25 |
Vertex Pharmaceuticals Incorporated |
ICE inhibitors for the treatment of autoinflammatory diseases
|
|
WO2005063739A1
(en)
|
2003-12-23 |
2005-07-14 |
Pfizer Inc. |
Novel quinoline derivatives
|
|
AU2005223610B2
(en)
|
2004-03-23 |
2008-05-29 |
Banyu Pharmaceutical Co., Ltd. |
Substituted quinazoline or pyridopyrimidine derivative
|
|
WO2005115145A2
(en)
|
2004-05-20 |
2005-12-08 |
Wyeth |
Quinone substituted quinazoline and quinoline kinase inhibitors
|
|
WO2005120509A1
(en)
|
2004-06-04 |
2005-12-22 |
Amphora Discovery Corporation |
Quinoline- and isoquinoline-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
|
FR2873695A1
(fr)
|
2004-07-30 |
2006-02-03 |
Palumed Sa |
Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien
|
|
BRPI0519267A2
(pt)
|
2004-12-22 |
2009-01-06 |
Bayer Schering Pharma Ag |
derivado de quinolina, seu uso, produÇço e medicamento contendo o mesmo
|
|
US8258145B2
(en)
|
2005-01-03 |
2012-09-04 |
Myrexis, Inc. |
Method of treating brain cancer
|
|
CA2603748A1
(en)
|
2005-04-06 |
2006-10-12 |
Exelixis, Inc. |
C-met modulators and methods of use
|
|
JO2787B1
(en)
|
2005-04-27 |
2014-03-15 |
امجين إنك, |
Alternative amide derivatives and methods of use
|
|
EP1746096A1
(en)
|
2005-07-15 |
2007-01-24 |
4Sc Ag |
2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer
|
|
ITMI20052008A1
(it)
|
2005-10-21 |
2007-04-22 |
Ctg Pharma S R L |
Nuovi antimalarici derivati della 4-aminochinolina
|
|
FR2902100A1
(fr)
|
2006-06-13 |
2007-12-14 |
Sanofi Aventis Sa |
Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique
|
|
US7511063B2
(en)
|
2006-08-16 |
2009-03-31 |
Schering Corporation |
High affinity quinoline-based kinase ligands
|
|
JP2008063278A
(ja)
|
2006-09-07 |
2008-03-21 |
Fujifilm Finechemicals Co Ltd |
１−ピリジン−４−イル−インドール類の製造方法
|
|
US20080221132A1
(en)
|
2006-09-11 |
2008-09-11 |
Xiong Cai |
Multi-Functional Small Molecules as Anti-Proliferative Agents
|
|
KR101434164B1
(ko)
|
2006-09-11 |
2014-08-26 |
쿠리스 인코퍼레이션 |
아연 결합 부분을 함유한 퀴나졸린 계열 ｅｇｆｒ 억제제
|
|
CA2662587C
(en)
|
2006-09-11 |
2013-08-06 |
Curis, Inc. |
Quinazoline based egfr inhibitors
|
|
TW200829555A
(en)
|
2006-11-10 |
2008-07-16 |
Astrazeneca Ab |
Chemical compounds
|
|
US8163923B2
(en)
|
2007-03-14 |
2012-04-24 |
Advenchen Laboratories, Llc |
Spiro substituted compounds as angiogenesis inhibitors
|
|
US8148532B2
(en)
|
2007-03-14 |
2012-04-03 |
Guoqing Paul Chen |
Spiro substituted compounds as angiogenesis inhibitors
|
|
US20080234267A1
(en)
|
2007-03-20 |
2008-09-25 |
Karen Elizabeth Lackey |
Compounds and Methods of Treatment
|
|
WO2008119771A2
(en)
|
2007-03-30 |
2008-10-09 |
Clanotech Ab |
Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors
|
|
BRPI0810462A2
(pt)
|
2007-04-23 |
2014-10-14 |
Sanofi Aventis |
Derivados de quinolina-carboxamida como antagonistas de p2y12
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
TW200908982A
(en)
|
2007-06-01 |
2009-03-01 |
Wyeth Corp |
Treatment of imatinib resistant leukemia
|
|
CN101362719B
(zh)
|
2007-08-06 |
2012-04-18 |
北京师范大学 |
喹啉类衍生物以及包含其的组合物
|
|
US7790746B2
(en)
|
2007-10-12 |
2010-09-07 |
Supergen, Inc. |
Quinoline derivatives for modulating DNA methylation
|
|
US7939546B2
(en)
|
2007-10-12 |
2011-05-10 |
Supergen, Inc. |
Quinoline derivatives for modulating DNA methylation
|
|
WO2009073746A1
(en)
|
2007-12-07 |
2009-06-11 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Apparatus for countercurrent chromatography
|
|
EP2072502A1
(de)
*
|
2007-12-20 |
2009-06-24 |
Bayer Schering Pharma Aktiengesellschaft |
Sulfoximid-substituierte Chinolin- und Chinazolinderivate als Kinase-Inhibitoren
|
|
GB0801416D0
(en)
|
2008-01-25 |
2008-03-05 |
Piramed Ltd |
Pharmaceutical compounds
|
|
AU2009221808A1
(en)
*
|
2008-03-06 |
2009-09-11 |
Genentech, Inc. |
Combination therapy with c-met and EGFR antagonists
|
|
BRPI0915240A2
(pt)
*
|
2008-10-17 |
2016-02-16 |
Genentech Inc |
método para tratar câncer, método para avaliação de um paciente submetido ao tratamento de câncer, método para avaliação de um paciente que tem ou com suspeita de ter câncer e uso de um anticorpo anti-c-met
|
|
DE102008062566A1
(de)
|
2008-12-16 |
2010-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Aminosäureester-Prodrugs und ihre Verwendung
|
|
PH12012500097A1
(en)
|
2009-07-21 |
2011-01-27 |
Shanghai Inst Organic Chem |
Potent small molecule inhibitors of autophagy, and methods of use thereof
|
|
WO2011112588A2
(en)
|
2010-03-08 |
2011-09-15 |
Case Western Reserve University |
Compositions and methods for treating inflammatory disorders
|
|
US20130023532A1
(en)
|
2010-03-26 |
2013-01-24 |
Casillas Linda N |
Indazolyl-pyrimidines as kinase inhibitors
|
|
JP2013523658A
(ja)
|
2010-03-26 |
2013-06-17 |
グラクソ グループ リミテッド |
キナーゼ阻害剤としてのピラゾリル‐ピリミジン
|
|
WO2011123609A1
(en)
|
2010-03-31 |
2011-10-06 |
Glaxo Group Limited |
Imidazolyl-imidazoles as kinase inhibitors
|
|
JP2013526484A
(ja)
|
2010-05-07 |
2013-06-24 |
グラクソ グループ リミテッド |
キナーゼ阻害剤としてのアミノ‐キノリン
|
|
UY33549A
(es)
|
2010-08-10 |
2012-01-31 |
Glaxo Group Ltd |
Quinolil aminas como agentes inhibidores de las quinasas
|
|
WO2012027495A1
(en)
|
2010-08-27 |
2012-03-01 |
University Of The Pacific |
Piperazinylpyrimidine analogues as protein kinase inhibitors
|
|
CA2820709C
(en)
|
2011-02-28 |
2016-02-16 |
Sunshine Lake Pharma Co., Ltd. |
Substituted quinoline compounds and methods of use
|
|
WO2012122011A2
(en)
|
2011-03-04 |
2012-09-13 |
Glaxosmithkline Llc |
Amino-quinolines as kinase inhibitors
|
|
TWI547494B
(zh)
*
|
2011-08-18 |
2016-09-01 |
葛蘭素史克智慧財產發展有限公司 |
作為激酶抑制劑之胺基喹唑啉類
|
|
TWI592417B
(zh)
|
2012-09-13 |
2017-07-21 |
葛蘭素史克智慧財產發展有限公司 |
胺基喹唑啉激酶抑制劑之前藥
|
|
TW201425307A
(zh)
|
2012-09-13 |
2014-07-01 |
Glaxosmithkline Llc |
作為激酶抑制劑之胺基－喹啉類
|
|
BR112015019624A2
(pt)
|
2013-02-21 |
2017-07-18 |
Glaxosmithkline Ip Dev Ltd |
quinazolinas como inibidores de quinase
|